A single dose of zoster vaccine is recommended for adults aged ≥60 years who have not previously received zoster vaccine. A dose is particularly recommended for adults who are 70–79 years of age.

In people aged 60–69 years, the incidence of both herpes zoster and post-herpetic neuralgia is high, and the vaccine is efficacious.1 However, the exact duration of vaccine efficacy is not known. Protection after a single vaccine dose wanes over time.2,3 The need for revaccination is not yet determined.

People aged 70–79 years are expected to benefit the most from routine zoster vaccination. Although vaccine efficacy against herpes zoster is lower in this age group than in people aged 50–69 years, people ≥70 years of age have a higher risk of both herpes zoster and post-herpetic neuralgia.1,4,5

In people aged ≥80 years, vaccination is less efficacious. People of this age may still receive some clinical benefit from being vaccinated.6

See Vaccine information and Epidemiology.

Page history

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018